Cookies?
Library Header Image
LSE Research Online LSE Library Services

Evidence of comparative efficacy should have a formal role in European drug approvals

Sorenson, Corinna and Naci, Huseyin and Cylus, Jonathan and Mossialos, Elias (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British Medical Journal, 343 (7822). d4849-d4849. ISSN 0959-8138

[img]
Preview
PDF
Download (306kB) | Preview

Identification Number: 10.1136/bmj.d4849

Abstract

Despite methodological concerns, comparative efficacy evidence should be required at the time of drug approval, says Corinna Sorenson and colleagues, to allow patients, clinicians, and other healthcare decision makers to determine whether a new drug is superior, equivalent, or inferior to its existing alternatives.

Item Type: Article
Official URL: http://www.bmj.com/
Additional Information: © 2011 BMJ Publishing Group
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RM Therapeutics. Pharmacology
Sets: Departments > Social Policy
Research centres and groups > LSE Health
Research centres and groups > ALPHA (Ageing, Lifecourse and Population Health Analysis)
Date Deposited: 09 Sep 2011 12:50
Last Modified: 29 May 2015 16:19
URI: http://eprints.lse.ac.uk/id/eprint/38191

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics